Omnicell Inc
OMCL37.070USD
-2.010-5.14%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
1.66BMarktkapitalisierung
830.42KGV TTM
mehr Informationen über Omnicell Inc Unternehmen
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Omnicell Inc Informationen
BörsenkürzelOMCL
Name des UnternehmensOmnicell Inc
IPO-datumAug 08, 2001
CEOLipps (Randall A)
Anzahl der mitarbeiter3670
WertpapierartOrdinary Share
GeschäftsjahresendeAug 08
Addresse4220 North Freeway
StadtFORT WORTH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl76137
Telefon18774159990
Websitehttps://www.omnicell.com/
BörsenkürzelOMCL
IPO-datumAug 08, 2001
CEOLipps (Randall A)
Führungskräfte von Omnicell Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
418.56K
-1147.00%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
86.83K
-4095.00%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+6828.00%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+7084.00%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+6862.00%
Mr. Edward Peter Bousa
Mr. Edward Peter Bousa
Independent Director
Independent Director
17.99K
+6486.00%
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
17.18K
+7084.00%
Mr. Kaushik (Bobby) Ghoshal
Mr. Kaushik (Bobby) Ghoshal
Independent Director
Independent Director
14.52K
+6401.00%
Mr. Corey J. Manley
Mr. Corey J. Manley
Executive Vice President, Chief Legal and Administrative Officer
Executive Vice President, Chief Legal and Administrative Officer
1.72K
-6608.00%
Mr. Mark W. Parrish
Mr. Mark W. Parrish
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
418.56K
-1147.00%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
86.83K
-4095.00%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+6828.00%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+7084.00%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+6862.00%
Mr. Edward Peter Bousa
Mr. Edward Peter Bousa
Independent Director
Independent Director
17.99K
+6486.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Connected devices, software licenses, and other
152.56M
49.11%
Technical services
67.28M
21.66%
SaaS and Expert Services
65.86M
21.20%
Consumables
24.94M
8.03%
Nach RegionUSD
Name
Umsatz
Anteil
United States
278.19M
89.56%
Rest of the World
32.44M
10.44%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Connected devices, software licenses, and other
152.56M
49.11%
Technical services
67.28M
21.66%
SaaS and Expert Services
65.86M
21.20%
Consumables
24.94M
8.03%
Aktionärsstatistik
Aktualisiert: Thu, Nov 20
Aktualisiert: Thu, Nov 20
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.92%
The Vanguard Group, Inc.
12.33%
Dimensional Fund Advisors, L.P.
5.27%
Cadian Capital Management LP
4.66%
State Street Investment Management (US)
4.57%
Andere
58.25%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.92%
The Vanguard Group, Inc.
12.33%
Dimensional Fund Advisors, L.P.
5.27%
Cadian Capital Management LP
4.66%
State Street Investment Management (US)
4.57%
Andere
58.25%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
47.07%
Investment Advisor/Hedge Fund
35.60%
Hedge Fund
15.19%
Research Firm
2.77%
Individual Investor
1.91%
Pension Fund
1.42%
Bank and Trust
0.74%
Sovereign Wealth Fund
0.37%
Family Office
0.05%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
617
46.23M
103.02%
-11.20M
2025Q3
643
48.76M
108.63%
-7.60M
2025Q2
681
49.10M
106.89%
-9.34M
2025Q1
708
50.20M
107.17%
-8.54M
2024Q4
716
48.64M
104.03%
-9.20M
2024Q3
742
47.70M
103.68%
-13.09M
2024Q2
766
48.23M
105.00%
-10.57M
2024Q1
786
47.95M
104.43%
-7.71M
2023Q4
812
47.51M
104.50%
-6.33M
2023Q3
817
49.57M
109.64%
-4.16M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
6.70M
14.92%
-120.44K
-1.77%
Sep 30, 2025
The Vanguard Group, Inc.
5.59M
12.46%
-26.01K
-0.46%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.36M
5.27%
+197.46K
+9.11%
Sep 30, 2025
Cadian Capital Management LP
2.09M
4.66%
+430.26K
+25.87%
Sep 30, 2025
State Street Investment Management (US)
2.05M
4.57%
-41.77K
-2.00%
Sep 30, 2025
Lazard Asset Management, L.L.C.
1.61M
3.58%
-100.35K
-5.87%
Sep 30, 2025
Amova Asset Management Co., Ltd.
1.40M
3.12%
-25.05K
-1.76%
Sep 30, 2025
D. E. Shaw & Co., L.P.
1.14M
2.55%
-279.48K
-19.66%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.12M
2.49%
-79.74K
-6.67%
Sep 30, 2025
Millennium Management LLC
841.53K
1.88%
+841.53K
--
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
1.88%
Global X HealthTech ETF
1.54%
ROBO Global Healthcare Technology & Innovation ETF
1.22%
Invesco S&P SmallCap Health Care ETF
0.94%
Langar Global HealthTech ETF
0.65%
Global X Robotics & Artificial Intelligence ETF
0.59%
Texas Capital Texas Small Cap Equity Index ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.55%
Distillate Small/Mid Cash Flow ETF
0.53%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil1.88%
Global X HealthTech ETF
Anteil1.54%
ROBO Global Healthcare Technology & Innovation ETF
Anteil1.22%
Invesco S&P SmallCap Health Care ETF
Anteil0.94%
Langar Global HealthTech ETF
Anteil0.65%
Global X Robotics & Artificial Intelligence ETF
Anteil0.59%
Texas Capital Texas Small Cap Equity Index ETF
Anteil0.59%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.55%
Federated Hermes MDT Small Cap Core ETF
Anteil0.55%
Distillate Small/Mid Cash Flow ETF
Anteil0.53%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
